188
Views
30
CrossRef citations to date
0
Altmetric
Original Research Article

Clinical experience with NuvaRing® in daily practice in Switzerland: Cycle control and acceptability among women of all reproductive ages

&
Pages 240-247 | Published online: 06 Jul 2009
 

Abstract

Objectives To assess clinical experience with NuvaRing® in daily practice in Switzerland, including a large subgroup of young women (aged ≤22 years).

Methods Open, prospective, multicentre, observational clinical experience study to investigate cycle control, acceptability and usage of NuvaRing®.

Results Altogether, 2642 women participated in the programme and were included in the analysis, of which 658 were aged ≤22 years (25% of the total group). A total of 744 women (28% of the total group) discontinued NuvaRing® use; the main reason was adverse events (11% of all users). In younger women, there was a shift from moderate (−18%) and heavy (−45%) bleeding to mild bleeding (+71%) and dysmenorrhoea decreased by 60%, despite previous hormonal contraception use by 83% of women. Most women found ring insertion and removal to be straightforward (>95%), and were satisfied with its use (85%), primarily for the ring's once-a-month application (81%). Data were very similar for the total group. Cycle control and satisfaction were further improved with duration of treatment.

Conclusions In daily practice, NuvaRing® improved cycle control and was highly acceptable to women, including young women. Switchers from other hormonal methods also showed improved cycle control and high satisfaction.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.